Esperion Therapeutics Inc (NASDAQ:ESPR)

23.76
Data as of Oct 23
 +0.59 / +2.55%
Today’s Change
10.90
Today|||52-Week Range
30.38
+72.93%
Year-to-Date

Today’s Trading

Previous close23.17
Today’s open23.26
Day’s range23.09 - 24.34
Volume248,054
Average volume (3 months)182,817
Market cap$471.1M
Dividend yield--
Data as of 3:59pm ET, 10/23/2014

Growth & Valuation

Earnings growth (last year)-5.75%
Earnings growth (this year)+20.90%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.80

Competitors

 Today’s
change
Today’s
% change
HPTXHyperion Therapeutic...+1.01+4.41%
ONVOOrganovo Holdings In...+0.03+0.51%
SZYMSolazyme Inc+0.11+1.74%
OSIROsiris Therapeutics ...+0.43+3.34%
Data as of 4:00pm ET, 10/23/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$0.00
Annual profit (last year)-$26.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Scientific Officer
Roger S. Newton
President, Chief Executive Officer &
Director
Tim M. Mayleben
Corporate headquarters
Ann Arbor, Michigan

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.